Join to View Full Profile
1295 Ustilago DrSan Ramon, CA 94582
Phone+1 925-234-0313
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Bijan Nejadnik, MD is a gastroenterologist in San Ramon, California. He is currently licensed to practice medicine in California.
Education & Training
Johns Hopkins UniversityFellowship, Gastroenterology, 2002 - 2005
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1994 - 1996
Cook County Health and Hospitals SystemInternship, Internal Medicine, 1993 - 1994
University Cath De LouvainClass of 1991
Certifications & Licensure
CA State Medical License 1998 - 2026
Publications & Presentations
PubMed
- 5 citationsModified human mesenchymal stromal/stem cells restore cortical excitability after focal ischemic stroke in rats.Barbara Klein, Agnieszka Ciesielska, Patricia Morán Losada, Anna Sato, Sajita Shah-Morales
Molecular Therapy. 2025-01-08 - 1 citationsMesenchymal Stromal Cell Implants for Chronic Motor Deficits After Traumatic Brain Injury: Post Hoc Analysis of a Randomized Trial.David O Okonkwo, Peter McAllister, Achal S Achrol, Yasuaki Karasawa, Masahito Kawabori
Neurology. 2024-10-08 - Mesenchymal Stem Cells Promote an Increase in Neuronal Oscillation via Glutamate Tonic Release.Ricardo L Azevedo-Pereira, Irina Aizman, Bijan Nejadnik
Neuroscience. 2024-08-06
Press Mentions
SanBio Announces Publication Comparing Outcome Measures for Persons with Chronic Traumatic Brain Injury in Expert Review of NeurotherapeuticsNovember 1st, 2021
Bijan Nejadnik, M.D., Appointed as Chief Medical Officer of SanBioMay 15th, 2019
Galena Biopharma Presents Positive Interim Safety Data on the NeuVax™ (Nelipepimut-S) Clinical Trial in Combination with Trastuzumab in High-Risk HER2 3+ Patients at the AACR Annual Meeting 2017April 4th, 2017- Join now to see all
